7 Results for "

Granta-519 cells

" in MedChemExpress (MCE) Product Catalog:
Products (7)

7 Results for "Granta-519 cells" in MCE Product Catalog:

Cat. No.: HY-144995
CAS No.: 2139329-47-6
Purity:  98.07%
Synonyms: CDK4/6-IN-11
Target:  

PROTACs CDK IKZF Family

Research Areas:  

Cancer

BSJ-02-162 (CDK4/6-IN-11) is a CDK4/CDK6 and IKZF1/IKZF3 degrader, with DC50 values of 32 nM and 6.1 nM against CDK4 and CDK6, respectively; its IC50 ranges from 1 to 50 nM. BSJ-02-162 induces G1-phase cell cycle arrest, reduces phosphorylated retinoblastoma protein levels, and exerts antiproliferative activity in mantle cell lymphoma cells. BSJ-02-162 is applicable to research related to mantle cell lymphoma .
loading...
    loading...
Cat. No.: HY-126256A
Purity:  99.50%
Research Areas:  

Cancer

PRMT5 IN-1 hydrochloride (compound 9), a hemiaminal, is a potent, selective protein arginine methyltransferase 5 (PRMT5) inhibitor with an IC50 of 11 nM for PRMT5/MEP50. PRMT5 IN-1 hydrochloride can be converted to aldehydes and react with C449 to form covalent adducts under physiological conditions .
loading...
    loading...
Cat. No.: HY-126256
CAS No.: 2366149-83-7
Research Areas:  

Cancer

PRMT5 IN-1, a hemiaminal, is a potent, selective protein arginine methyltransferase 5 (PRMT5) inhibitor with an IC50 of 11 nM for PRMT5/MEP50. PRMT5 IN-1 can be converted to aldehydes and react with C449 to form covalent adducts under physiological conditions .
loading...
    loading...
Cat. No.: HY-136342
CAS No.: 2355185-12-3
Target:  

Others

Research Areas:  

Cancer

Antitumor agent-23 is a potent anti-cancer agent with GI50s of 38, 48, 5, 27, 80, and 28 nM for lymphoma cell line GRANTA-519, KARPAS-422, KARPAS-299, RAMOS, DAUDI, and RAJI, respectively. Antitumoral activity .
loading...
    loading...
Cat. No.: HY-P991590
CAS No.: 791073-97-7

Research Areas:  

Cancer

1D09C3 is a fully human anti-HLA-DR monoclonal antibody. 1D09C3 induces apoptosis and cell death involving a cascade of events, including ROS generation, JNK activation, mitochondrial membrane depolarization, and AIF release from mitochondria. 1D09C3 shows potent anti-tumor activity and increases overall survival and median survival in JVM-2 cells and GRANTA-519 cells xenograft mice models. 1D09C3 can be used for the researches of cancer, such as chronic lymphocytic leukemia (CLL) .
loading...
    loading...
Cat. No.: HY-168190
Target:  

PROTACs

Research Areas:  

Cancer

PROTAC TBL1X degrader-1 is a TBL1X PROTAC degrader. PROTAC TBL1X degrader-1 induces TBL1X degradation via the Cereblon-mediated proteasomal pathway. PROTAC TBL1X degrader-1 exerts cytotoxic effects on cancer cells. PROTAC TBL1X degrader-1 can be used in studies related to diffuse large B-cell lymphoma .
loading...
    loading...
Cat. No.: HY-P11779
CAS No.: 2768774-89-4
Ac-RKAA-PABC-MMAE is a Drug-Linker Conjugates for ADC. Ac-RKAA-PABC-MMAE consists of the ADC Cytotoxin MMAE (HY-15162) and a linker. Ac-RKAA-PABC-MMAE can be used for synthesis of ADCs .
loading...
    loading...